Robert W. Simms
Impact in
- Pathology and Forensic Medicine top 0.02%
- Systemic Sclerosis and Related Diseases
- Pulmonary and Respiratory Medicine top 0.5%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Pulmonary Hypertension Research and Treatments
Papers in
-
- Systemic Sclerosis and Related Diseases 82
-
- Pulmonary Hypertension Research and Treatments 16
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Vasculitis and related conditions 2
- Co-authors
- Don L. Goldenberg (5 shared papers)Robert Lafyatis (19 shared papers)Martha Skinner (10 shared papers)Maria Trojanowska (3 shared papers)David T. Felson (6 shared papers)John Varga (4 shared papers)Alan S. Cohen (7 shared papers)Christopher P. Denton (1 shared paper)
- Journals
- Arthritis & Rheumatology (10 papers)Arthritis Care & Research (6 papers)Arthritis Research & Therapy (6 papers)Annals of the Rheumatic Diseases (6 papers)Lara D. Veeken (5 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Robert W. Simms
130 papers receiving 16.6k citations
Robert W. Simms's Hit Papers
Peers
Comparison fields: 5 of 131
- Pathology and Forensic Medicine 10.3k
- Pulmonary and Respiratory Medicine 2.7k
- Rheumatology 1k
- Psychiatry and Mental health 826
- Orthopedics and Sports Medicine 195
Countries citing papers authored by Robert W. Simms
This map shows the geographic impact of Robert W. Simms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Simms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Simms more than expected).
Fields of papers citing papers by Robert W. Simms
This network shows the impact of papers produced by Robert W. Simms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Simms. The network helps show where Robert W. Simms may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert W. Simms, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative Hit paper breakdown → | 2013 | 2813 |
| 2 | 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative Hit paper breakdown → | 2013 | 2284 |
| 3 | Cyclophosphamide versus Placebo in Scleroderma Lung Disease Hit paper breakdown → | 2006 | 1329 |
| 4 | Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial Hit paper breakdown → | 2016 | 828 |
| 5 | Systemic sclerosis Hit paper breakdown → | 2015 | 686 |
| 6 | Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist Hit paper breakdown → | 2004 | 569 |
| 7 | Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2020 | 500 |
| 8 | Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma Hit paper breakdown → | 2018 | 439 |
| 9 | 2007 | 359 | |
| 10 | Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients Hit paper breakdown → | 2015 | 302 |
| 11 | 1996 | 298 | |
| 12 | 2002 | 284 | |
| 13 | Guidelines for the Management of Rheumatoid Arthritis | 2002 | 261 |
| 14 | 1990 | 248 | |
| 15 | 2009 | 240 | |
| 16 | 2000 | 225 | |
| 17 | 1996 | 192 | |
| 18 | 2013 | 182 | |
| 19 | 2014 | 176 | |
| 20 | 2019 | 176 |
About Robert W. Simms
Robert W. Simms is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Psychiatry and Mental health, Rheumatology and Molecular Biology, having authored 131 papers that have together received 17.3k indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (82 papers), Pulmonary Hypertension Research and Treatments (16 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (13 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (12 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Bone health and osteoporosis research (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Vasculitis and related conditions (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (10.3k citations), Pulmonary and Respiratory Medicine (2.7k citations), Rheumatology (1k citations), Psychiatry and Mental health (826 citations) and Orthopedics and Sports Medicine (195 citations). Robert W. Simms has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Don L. Goldenberg, Robert Lafyatis, Martha Skinner, Maria Trojanowska, David T. Felson, John Varga, Alan S. Cohen, Christopher P. Denton, Oliver Distler and Janet Elizabeth Pope. Their work appears in journals such as Arthritis & Rheumatology, Arthritis Care & Research, Arthritis Research & Therapy, Annals of the Rheumatic Diseases and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.